A mass balance study of [14C]-lenalidomide following oral administration in healthy male subjects

被引：0
|
作者：
Chen, N. [1 ]
Kumar, G. [1 ]
Lau, H. [1 ]
Laskin, O. [1 ]
机构：
[1] Celgene Corp, Summit, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2008年 / 48卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
29
引用
收藏
页码：1105 / 1105
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics of [14C]Ciclesonide After Oral and Intravenous Administration to Healthy Subjects
    Ruediger Nave
    Thomas D. Bethke
    Sjoerd P. van Marle
    Karl Zech
    Clinical Pharmacokinetics, 2004, 43 : 479 - 486
  • [22] Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects
    Nave, R
    Bethke, TD
    van Marle, SP
    Zech, K
    CLINICAL PHARMACOKINETICS, 2004, 43 (07) : 479 - 486
  • [23] Mass balance and pharmacokinetics of an oral dose of 14C-napabucasin in healthy adult male subjects
    Dai, Xiaoshu
    Karol, Michael D.
    Hitron, Matthew
    Hard, Marjie L.
    Blanchard, John Evan
    Eraut, Nicola C. J. E.
    Rich, Natalie
    Gufford, Brandon T.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (01):
  • [24] Mass balance and pharmacokinetics of an oral dose of 14C-napabucasin in healthy adult male subjects
    Dai, Xiaoshu
    Karol, Michael D.
    Hitron, Matthew
    Hard, Marjie
    Blanchard, J. Evan
    Eraut, Nicola
    Rich, Natalie
    Gufford, Brandon
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [25] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Yiming Cheng
    Xiaomin Wang
    Liangang Liu
    Jose Silva
    Michael Thomas
    Yan Li
    European Journal of Drug Metabolism and Pharmacokinetics, 2024, 49 : 355 - 365
  • [26] A Phase I, Open-Label, Mass Balance Study of [14C]-Iberdomide in Healthy Subjects
    Cheng, Yiming
    Wang, Xiaomin
    Liu, Liangang
    Silva, Jose
    Thomas, Michael
    Li, Yan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 355 - 365
  • [27] ADME STUDY OF [14C]NETUPITANT ADMINISTERED AS AN ORAL 300 MG SUSPENSION TO HEALTHY MALE SUBJECTS
    Giuliano, C.
    Calcagnile, S.
    Mair, S.
    Stevens, L.
    Nisbet, I.
    ANNALS OF ONCOLOGY, 2012, 23 : 508 - 508
  • [28] Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects
    Peeters, PAM
    Van Lier, JJ
    Van De Merbel, N
    Oosterhuis, B
    Wieling, J
    Jonkman, JHG
    Klessing, K
    Biber, A
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (01) : 45 - 53
  • [29] Pharmacokinetics of [14C]-labelled losigamone and enantiomers after oral administration to healthy subjects
    P. A. M. Peeters
    J. J. Van Lier
    N. Van De Merbel
    B. Oosterhuis
    J. Wieling
    J. H. G. Jonkman
    K. Klessing
    A. Biber
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 45 - 53
  • [30] ABSORPTION DISTRIBUTION METABOLISM AND EXCRETION OF ORAL [14C]-IBREXAFUNGERP IN HEALTHY MALE SUBJECTS
    Azie, N.
    Angulo, D.
    Evans, P.
    Murphy, G.
    Ghahramani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S12 - S12
12345